Free Trial

Akash Tewari Analyst Performance

Analyst at Wolfe Research

Akash Tewari is a stock analyst at Wolfe Research, covering 10 publicly traded companies across a range of sectors. Over the past year, Akash Tewari has issued 6 stock ratings, including buy and hold recommendations. While full access to Akash Tewari's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Akash Tewari's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
13 Last 4 Years
Buy Recommendations
63.64% 7 Buy Ratings
Companies Covered
10 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy63.6%7 ratings
Hold27.3%3 ratings
Sell9.1%1 ratings

Out of 11 total stock ratings issued by Akash Tewari at Wolfe Research, the majority (63.6%) have been Buy recommendations, followed by 27.3% Hold and 9.1% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
80.0% of companies on NASDAQ
8 companies
NYSE
20.0% of companies on NYSE
2 companies

Akash Tewari, an analyst at Wolfe Research, currently covers 10 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
10 companies
100.0%

Akash Tewari of Wolfe Research specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
6 companies
60.0%
MED - DRUGS
2 companies
20.0%
LARGE CAP PHARMA
1 company
10.0%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC
1 company
10.0%

Akash Tewari's Ratings History at Wolfe Research

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
9/2/2025Boost Price Target$57.43$96.00Buy
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
8/27/2025Boost Price Target$587.65$831.00Buy
Crescent Biopharma, Inc. stock logo
CBIO
Crescent Biopharma
8/25/2025Initiated Coverage$15.06$26.00Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
7/15/2025Set Price Target$58.23$95.00Outperform
Arvinas, Inc. stock logo
ARVN
Arvinas
5/2/2025Reiterated Rating$7.23$10.00Hold
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
4/23/2025Lower Price Target$49.82$68.00Buy